Helicobacter pylori–specific Protection Against Inflammatory Bowel Disease Requires the NLRP3 Inflammasome and IL-18
Conclusions: In summary, we propose here that the immunomodulatory activity of an ancient constituent of the gut microbiota, H. pylori, may be exploited for the prevention and/or treatment of inflammatory bowel diseases.
Source: Inflammatory Bowel Diseases - Category: Gastroenterology Tags: Original Basic Science Articles Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Cancer & Oncology | Carcinoma | Crohn's Disease | Diabetes | Endocrinology | Endoscopy | Gastric (Stomach) Cancer | Gastritis | Gastroenterology | Genetics | Helicobacter Pylori | Inflammatory Bowel Disease | Multiple Sclerosis | Science | Ulcerative Colitis